Source - SMW
Small molecule drug developer Sareum Holdings noted that two abstracts reporting updated clinical data had been accepted for presentation at the American Society of Clinical Oncology annual meeting in Chicago.

The data related to an ongoing Phase I/IIa trial with cancer treatment SRA737.

The abstracts would be published on 15 May, with both abstracts scheduled to be presented on 1 June.